https://www.avient.com/sites/default/files/2023-07/Avient_CodeConduct_2023_Portuguese.pdf
Criamos uma empresa com uma ótima dinâmica: uma empresa com alcance global e uma visão clara.
Esses valores formam um compromisso que nós, como colaboradores da Avient, assumimos uns com os outros, com nossas partes interessadas e com nossas comunidades.
Com esse objetivo, proibimos o uso de qualquer forma de trabalho infantil em conexão com os negócios da Avient.
https://www.avient.com/sites/default/files/2022-08/Avient Candidates Data Privacy Notice Final - Portuguese.pdf
Por favor, leia este Aviso com atenção.
Prestadores de serviço: prestadores de serviços, tais como aqueles que nos ajudam com a operação de nossos sistemas de recrutamento on-line ou que são contratados para ajudar com o processo de candidatura (por exemplo, com suporte técnico para esta plataforma de recrutamento), são selecionados com cuidado.
Para que os seus dados sejam tratados com confidencialidade e segurança, os contratos com prestadores de serviços contêm disposições que resguardam seus dados em conformidade com as leis vigentes.
https://www.avient.com/sites/default/files/2021-03/avient-antitrust-2021-update-port-a4.pdf
Além da prevenção de penalidades legais, a conformidade com as leis antitruste está de acordo com o compromisso da Avient com a conduta ética.
Contatos com concorrentes.
Evite contatos desnecessários com concorrentes. 2.
https://www.avient.com/sites/default/files/2020-09/avient-candidates-data-privacy-notice-final-portuguese.pdf
Por favor, leia este Aviso com atenção.
Prestadores de serviço: prestadores de serviços, tais como aqueles que nos ajudam com a operação de nossos sistemas de recrutamento on-line ou que são contratados para ajudar com o processo de candidatura (por exemplo, com suporte técnico para esta plataforma de recrutamento), são selecionados com cuidado.
Para que os seus dados sejam tratados com confidencialidade e segurança, os contratos com prestadores de serviços contêm disposições que resguardam seus dados em conformidade com as leis vigentes.
https://www.avient.com/news/archives?page=47
MANNHEIM, Germany - March 14, 2018 - Advanced polymers, colorants, and additives from PolyOne are enabling automotive manufacturers to develop new com
https://www.avient.com/resources/safety-data-sheets?page=5624
MORADO OPACO PANTONE Q260-1-3 EN PS
https://www.avient.com/sites/default/files/2024-06/Cesa Flame Retardant Product Selection Guide %281%29.pdf
PE Control Conventional FR Cesa F-Series 1 Cesa F-Series 2 Time, Seconds H ea t R el ea se R at e kW /m 2 2000 1500 1000 500 0 1.844.4AVIENT www.avient.com Copyright © 2024, Avient Corporation.
POLYMER PRODUCT NAME PROPERTY PERFORMANCE TYPE DOSAGE/ LDR MATERIAL CODE ABS FRABS92991 UL 94 Halogen 35% CC10292991WE ABS FRABS52399 UL 94 Halogen 5–14% CC10252399WE HDPE Cesa Flam MB 5101AH UL 94 Halogen 7–16% PEAN698479 Nylon Cesa Flam MB 5728H UL 94 Halogen 8–14% ABA0698450 Nylon Cesa Flam MB 5731NH UL 94 Non-halogen 8–20% ABAN698410 PC Cesa Flam NCA0820018NH UL 94 Non-halogen 2–4% NCA0820018 PC NCAN-Z0N-FN FLMRET 698419 UL 94 Non-halogen 3–8% NCAN698419 PE FRPE94802 ASTM E84 Non-halogen 100% CC103094802F PE FRPE41011 UL 94 Halogen 20–30% CC1034101160 PET Cesa Flam MB 5525NH UL 1441, UL 94 Non-halogen 6–8% NEAN698534 PET FRPET65462 UL 94 Non-halogen 5–12% CC103265462F PET/ PBT Cesa Flam MB 5532NH NFPA 701 Non-halogen 4–6% NBAN698451 PP Cesa Flam MB 5201H UL 94 Halogen 6–30% PPAN698410 PP Cesa Flam MB CT-1629NH Cal TB 133, UL 94 Film, NFPA 701 Non-halogen 6–8% PPAN698428 PP FRPP365370 UL 94 Non-halogen 10–20% CC103653702F PP Copolymer FRPP37654 UL 94 5VA Halogen 100% CC10337654WE PP Copolymer FRPP53484 UL 94 Halogen 10% CC1035348460 PS FRPS62722 ASTM E84 Halogen 2–4% CC10262722WE PS/HIPS Cesa Flam SLA0820014H UL 94 Halogen 4–8% SLA0820014H TPU Cesa Flam 98461NH UL 94 Non-halogen 6–14% RUA0698461 F-SERIES FLAME RETARDANT ADDITIVES HDPE/PE F-Series UL 94 Non-halogen 10–25% PEA0820024 PE F-Series UL 2335, FM 4998 Non-halogen 10–25% PEA0820069
https://www.avient.com/sites/default/files/2025-04/Supplier Code of Conduct FV_Port.pdf
Os registos contabilísticos devem estar disponíveis para a Avient, mediante pedido. • Evitar conflitos de interesses que envolvam negócios com membros da família e amigos próximos da Avient.
Tratar todas as transações e negociações com a Avient como confidenciais e exclusivas.
Para questões relacionadas com esta política, contactar sourcing@avient.com.
https://www.avient.com/sites/default/files/2021-06/avient-ir-presentation-june-2021-w-non-gaap-recs_0.pdf
D is t. ) K W R R P M P P G A V Y F U L G C P H X L F M C F O E IF F H U N E C L A S H E M N K R A C E S C L G R A A LB Median: 5%Median: 3% Source: Peer data per Bloomberg market data as of June 4, 2021 Avient reflects 2021 estimated revenue of $4,300M and excludes one-time synergy capture CAPEX ($20M) Avient Specialty Formulators Other Chemical/Specialty Companies Free Cash Flow Conversion (1) 2021E (%) Being asset light helps us to generate strong free cash flow that is in line with specialty formulators.
Free cash flow conversion calculated as (EBITDA – Capex) / EBITDA Median: 84% Median: 78% HIGH FREE CASH FLOW CONVERSION Avient reflects 2021 estimated EBITDA of $560M and excludes one-time synergy capture CAPEX ($20M) Source: Peer data per Bloomberg market data as of June 4, 2021 87 89 87 86 83 81 76 88 85 83 82 81 80 78 78 78 76 72 71 69 50 18 A vi en t K W R P P G R P M A V Y F U L G C P F M C H X L U N V R IF F E C L A S H F O E C E E M N B N R H U N G R A K R A S C L A L B Source: Peer data per Bloomberg market data as of June 4, 2021 Total Enterprise Value / 2021E EBITDA Our current valuation with updated guidance implies an EBITDA multiple that is below specialty formulator peers and the majority of our chemical peers.
With the Clariant Masterbatch acquisition and divestment of the PP&S business, our exposure is now concentrated in less-cyclical and high-growth markets, with increased geographic diversification and a more specialized portfolio that can significantly expand EBITDA margins. 28 Avient reflects 2021 estimated EBITDA of $560M OUR VALUATION VERSUS PEERS Avient Specialty Formulators Other Chemical/Specialty Companies 10.4 18.2 16.0 15.5 15.3 11.3 11.0 29.7 26.5 23.5 18.2 13.4 11.9 11.9 11.7 10.5 10.4 10.3 10.1 9.7 7.7 6.5 A vi en t K W R A V Y P P G R P M F U L G C P H X L A L B E C L IF F F M C B N R A S H G R A E M N F O E S C L U N V R C E K R A H U N Median: 11.7xMedian: 15.4x SUMMARY: WHY INVEST IN AVIENT?
https://www.avient.com/sites/default/files/2021-09/avnt-seaport-conference-presentation.pdf
D is t. ) K W R P P G A V Y F U L R P M G C P H X L F M C H U N IF F E C L A S H K R A E M N C E S C L A LB Median: 5%Median: 3% Source: Peer data per Bloomberg market data as of July 28, 2021 Avient reflects 2021 estimated revenue of $4,650M and excludes one-time synergy capture CAPEX ($20M) Avient Specialty Formulators Other Chemical/Specialty Companies Free Cash Flow Conversion (1) 2021E (%) Being asset light helps us to generate strong free cash flow that is in line with specialty formulators.
Free cash flow conversion calculated as (EBITDA – Capex) / EBITDA Median: 81% Median: 78% HIGH FREE CASH FLOW CONVERSION Avient reflects 2021 estimated EBITDA of $580M and excludes one-time synergy capture CAPEX ($20M) Source: Peer data per Bloomberg market data as of July 28, 2021 87 90 86 82 80 78 73 87 82 82 79 79 78 78 77 76 71 67 46 A vi en t K W R P P G A V Y F U L R P M G C P F M C U N V R C E IF F A S H E C L B N R E M N H X L H U N K R A S C L A L B (6) Source: Peer data per Bloomberg market data as of July 28, 2021 Total Enterprise Value / 2021E EBITDA Our current valuation with updated guidance implies an EBITDA multiple that is below specialty formulator peers and the median of other selected chemical / specialty companies.
With the Clariant Masterbatch acquisition and divestment of the PP&S business, our exposure is now concentrated in less-cyclical and high-growth markets, with increased geographic diversification and a more specialized portfolio that can significantly expand EBITDA margins. 31 Avient reflects 2021 estimated EBITDA of $580M OUR VALUATION VERSUS PEERS Avient Specialty Formulators Other Chemical/Specialty Companies 9.5 18.5 15.1 15.1 14.0 11.0 10.4 29.5 28.2 23.9 18.7 12.4 12.2 11.1 9.3 9.2 9.2 7.6 7.6 6.0 A vi en t K W R P P G A V Y R P M F U L G C P A L B H X L E C L IF F F M C B N R A S H S C L E M N U N V R K R A C E H U N Median: 11.1xMedian: 14.6x SUMMARY: WHY INVEST IN AVIENT?